Get my own profile
Public access
View all1 article
2 articles
available
not available
Based on funding mandates
Co-authors
Andrei LupasDirector of the Department of Protein Evolution, Max-Planck-Institute for BiologyVerified email at tuebingen.mpg.de
James R BrownSelf-employedVerified email at drexel.edu
Peter G. WolynesBullard-Welch Foundation Professor of Science, Professor of Chemistry, Professor of PhysicsVerified email at rice.edu
Benjamin BaxResearch FellowVerified email at cardiff.ac.uk
Zaida (Zan) Luthey-SchultenUniversity of Illinois at Urbana-ChampaignVerified email at illinois.edu
Roiban Gheorghe-DoruGlaxoSmithKline plcVerified email at gsk.com
Chaya DuraiswamiProduct Director (Safety & Efficacy), GlaxosmithklineVerified email at gsk.com
Sergej DjuranovicProfessor of Cell Biology and Physiology, Washington UniversityVerified email at wustl.edu
Rob RussellProfessor of Protein Evolution, BioQuant/BZH, Heidelberg University, GermanyVerified email at bioquant.uni-heidelberg.de
Peter GoughInzen TherapeuticsVerified email at inzentx.com
John D LichPharmaVerified email at gsk.com
John BertinSanofiVerified email at sanofi.com
Vikram AlvaGroup Leader, Max Planck Institute for BiologyVerified email at tuebingen.mpg.de
Philippe SanseauGSKVerified email at gsk.com
Markus GruberNokia Bell LabsVerified email at nokia.com
Peter TumminoChief Scientific Officer, Nimbus TherapeuticsVerified email at nimbustx.com
Robert A. CopelandPresident & CSO, Accent Therapeutics, Inc.Verified email at accenttx.com